18FFlorbetapir

18F Florbetapir is a radioactive tracer used in positron emission tomography (PET) imaging. Its primary use is to detect and quantify amyloid-beta plaques in the brain. Amyloid-beta plaques are abnormal protein deposits that are a hallmark of Alzheimer's disease and other neurodegenerative conditions. By binding to these plaques, 18F florbetapir allows physicians to visualize their distribution and density through PET scans. This imaging can aid in the diagnosis of Alzheimer's disease, particularly in distinguishing it from other causes of dementia, and can be used in clinical trials to assess the effectiveness of potential new Alzheimer's treatments targeting amyloid-beta. The tracer is administered intravenously and then detected by the PET scanner as it accumulates in the brain. The uptake of 18F florbetapir is generally higher in individuals with Alzheimer's disease compared to healthy individuals. It is important to note that the presence of amyloid-beta plaques, while a characteristic of Alzheimer's, does not definitively confirm the diagnosis on its own, and imaging results are interpreted in conjunction with other clinical information.